AI
ASMB icon

Acuitas Investments’s Assembly Biosciences ASMB Stock Holding History

Acuitas Investments’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-62,315
Closed -$943K – 71
2024
Q3 		$943K Buy
62,315
+12,319
+25% +$188K 0.42% 80
2024
Q2 		$686K Buy
49,996
+264
+0.5% +$3.77K 0.37% 84
2024
Q1 		$661K Buy
49,732
+27,600
+125% +$322K 0.33% 89
2023
Q4 		$218K Buy
+22,132
New +$210K 0.11% 109

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCM
Monimus Capital Management Woodbridge, New Jersey $432M AUM 20.27% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Acuitas Investments's ASMB Position: Q4 2024 in Review

Acuitas Investments sold out of Assembly Biosciences (ASMB) in Q4 2024, closing a stake of 62,315 shares — an estimated $943K sold.

Acuitas Investments first reported a position in ASMB in Q4 2023 and held it in 4 quarters. The position peaked at $943K in Q3 2024. 35 funds tracked by Wall St. Rank hold ASMB as of Q4 2024.

  • Acuitas Investments reported no remaining Assembly Biosciences position as of Q4 2024 after selling out during the quarter.
  • Acuitas Investments sold 62,315 Assembly Biosciences shares in Q4 2024, an estimated $943K.
  • Acuitas Investments first reported a position in Assembly Biosciences in Q4 2023 and held it in 4 quarters.
  • Acuitas Investments's Assembly Biosciences position peaked at $943K in Q3 2024.
  • 35 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2024.

Based on Acuitas Investments's 13F filing for Q4 2024, filed 31 Jan 2025.